In the UK, Impact Research has appointed Holden Pearmain's former Pharmaceutical Director Jamie Margerison to lead a new healthcare division, Impact Healthcare.Impact was set up in 2010 by former Holden Pearmain colleagues Darryl Swift and Michael Brainch, to focus on client s in the utilities, retail and FMCG sectors. Last year, Holden Pearmain co-founder David Pearmain joined the company as Director of Advanced Analytics.
Margerison (pictured) also joins from Holden Permain, where he worked for more than nine years, after beginning his career at Research International.
Commenting on the launch, Margerison said: 'Impact Healthcare will be dedicated to offering world-class research solutions. With the team's industry experience, motivated attitude and leading advanced method capabilities, we believe we have a winning combination.'
His arrival follows the recent appointment of Liz Rattray and Manjula Bhudiya as Associate Directors.
Web site: www.impactmr.com .
All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.
Register (free) for Daily Research News
REGISTER FOR NEWS EMAILS
To receive (free) news headlines by email, please register online